These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 17997810

  • 21. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
    Fattah Z, Isenberg DA.
    Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
    [Abstract] [Full Text] [Related]

  • 22. New developments in the treatment of systemic lupus erythematosus.
    Tullus K.
    Pediatr Nephrol; 2012 May; 27(5):727-32. PubMed ID: 21516516
    [Abstract] [Full Text] [Related]

  • 23. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E, Sysa-Jedrzejowska A, Wozniacka A.
    Przegl Lek; 2005 May; 62(9):894-9. PubMed ID: 16541725
    [Abstract] [Full Text] [Related]

  • 24. [New treatments for systemic diseases].
    Bader-Meunier B, Willems M.
    Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
    [No Abstract] [Full Text] [Related]

  • 25. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
    Furie R, Toder K, Zapantis E.
    Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553
    [Abstract] [Full Text] [Related]

  • 26. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH, Aringer M.
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [Abstract] [Full Text] [Related]

  • 27. SLE - Rituximab in lupus.
    Eisenberg R.
    Arthritis Res Ther; 2003 Oct; 5(4):157-9. PubMed ID: 12823844
    [Abstract] [Full Text] [Related]

  • 28. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP, Rosado MM, Carsetti R, Valesini G.
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [Abstract] [Full Text] [Related]

  • 29. New biologic therapy for systemic lupus erythematosus.
    Ding HJ, Gordon C.
    Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
    [Abstract] [Full Text] [Related]

  • 30. New therapies for systemic lupus erythematosus: cellular targets.
    Looney RJ, Anolik J, Sanz I.
    Rheum Dis Clin North Am; 2006 Feb; 32(1):201-15, xi. PubMed ID: 16504831
    [Abstract] [Full Text] [Related]

  • 31. Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus.
    Jordan N, Lutalo PM, D'Cruz DP.
    Immunotherapy; 2015 Feb; 7(3):255-70. PubMed ID: 25804478
    [Abstract] [Full Text] [Related]

  • 32. Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future.
    Sfikakis PP, Boletis JN, Tsokos GC.
    Curr Opin Rheumatol; 2005 Sep; 17(5):550-7. PubMed ID: 16093832
    [Abstract] [Full Text] [Related]

  • 33. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 34. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells.
    Looney RJ, Anolik J, Sanz I.
    Lupus; 2004 May; 13(5):381-90. PubMed ID: 15230297
    [Abstract] [Full Text] [Related]

  • 35. Antibody-based therapies in systemic lupus erythematosus.
    Iikuni N, La Cava A.
    Mini Rev Med Chem; 2009 Jun; 9(7):829-46. PubMed ID: 19519508
    [Abstract] [Full Text] [Related]

  • 36. Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou P, Kukar M, Hersh A.
    Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
    [No Abstract] [Full Text] [Related]

  • 37. [Rituximab (anti-CD20 monoclonal antibody) for refractory systemic lupus erythematosus: report of one case].
    Sabugo F, Llanos C, Soto L, Gutiérrez J, Cuchacovich M.
    Rev Med Chil; 2005 Jun; 133(6):681-4. PubMed ID: 16075133
    [Abstract] [Full Text] [Related]

  • 38. New therapeutic avenues in SLE.
    Bakshi J, Ismajli M, Rahman A.
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):794-809. PubMed ID: 27107514
    [Abstract] [Full Text] [Related]

  • 39. Rituximab and lupus--a promising pair?
    Ekö SL, van Vollenhoven RF.
    Curr Rheumatol Rep; 2014 Dec; 16(9):444. PubMed ID: 25074032
    [Abstract] [Full Text] [Related]

  • 40. Lupus, the current therapeutic approaches.
    Wong M, La Cava A.
    Drugs Today (Barc); 2011 Apr; 47(4):289-302. PubMed ID: 21573252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.